Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

NCT06064591 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT06064591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06064591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Completed
Start date
December 13, 2023
Completion date
December 9, 2025
Enrollment
458 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

asyptomatic plasmodium infection, severe malaria, uncomplicated malaria